SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-022958
Filing Date
2019-11-14
Accepted
2019-11-14 17:22:00
Documents
14
Period of Report
2019-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20191114_8k.htm 8-K 27364
2 EXHIBIT 99.1 ex_165063.htm EX-99.1 154085
3 EXHIBIT 99.2 ex_165064.htm EX-99.2 5985
4 a1.jpg GRAPHIC 11754
5 slide01.jpg GRAPHIC 46044
6 slide02.jpg GRAPHIC 273822
7 slide03.jpg GRAPHIC 56892
8 slide04.jpg GRAPHIC 60906
9 slide05.jpg GRAPHIC 149775
10 slide06.jpg GRAPHIC 117172
11 slide07.jpg GRAPHIC 115085
12 slide08.jpg GRAPHIC 148191
13 slide09.jpg GRAPHIC 123713
14 slide10.jpg GRAPHIC 65908
  Complete submission text file 0001437749-19-022958.txt   1794684
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 191221665
SIC: 2834 Pharmaceutical Preparations